Left atrial appendage closure devices: A reasonable therapeutic alternative-Reference-Cited by-同舟云学术

Left atrial appendage closure devices: A reasonable therapeutic alternative

Published:2018-02 Issue:2 Volume:15 Page:302-305
ISSN:1547-5271
Container-title:Heart Rhythm
language:en
Short-container-title:Heart Rhythm

Author:

Reddy Vivek Y.

Publisher

Elsevier BV

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference13 articles.

1. Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial;Reddy;JAMA,2014

2. The safety of percutaneous left atrial appendage closure: results from PROTECT-AF and the continued access registry;Reddy;Circulation,2011

3. Post-FDA approval, initial US clinical experience with Watchman Left Atrial Appendage Closure for stroke prevention in atrial fibrillation;Reddy;J Am Coll Cardiol,2017

4. Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial;Holmes;J Am Coll Cardiol,2014

5. Circulatory System Devices Panel: Watchman Left Atrial Appendage Closure Therapy Sponsor Presentation. 2014 FDA Circulatory System Devices Panel. Available at: https://wayback.archive-it.org/7993/20170114045413/http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/MedicalDevices/MedicalDevicesAdvisoryCommittee/CirculatorySystemDevicesPanel/UCM421983.pdf.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Feasibility and safety of a percutaneous and non-fluoroscopic procedure for left atrial appendage closure in patients for whom fluoroscopy presents risk: a cohort study;Quantitative Imaging in Medicine and Surgery;2023-09

2. Transcatheter Left Atrial Appendage Closure: Devices Available, Pitfalls, Advantages, and Future Directions;US Cardiology Review;2023-05-25

3. The Impact of Dabigatran and Rivaroxaban on Variation of Platelet Activation Biomarkers and DRT Following Percutaneous Left Atrial Appendage Closure;Frontiers in Pharmacology;2021-09-15

4. Clinical Efficacy and Safety Comparison of Rivaroxaban and Dabigatran for Nonvalvular Atrial Fibrillation Patients Undergoing Percutaneous Left Atrial Appendage Closure Operation;Frontiers in Pharmacology;2021-06-18

5. Cessation of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation;Heart;2020-10-16